Israel Englander Acorda Therapeutics Inc Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.55 - $1.0 $12,618 - $22,943	-22,943 Reduced 11.62%	174,483 $102,000
Q4 2022 Feb 14, 2023	BUY	$0.52 - $0.77 $3,747 - $5,548	7,206 Added 3.79%	197,426 $151,000
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.53 $35,173 - $64,283	-121,289 Reduced 38.94%	190,220 $57,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.